Michel Vounatsos serves as Executive at BIOGEN INC., where they oversee executive responsibilities. Since joining the company, Michel Vounatsos has executed 54 insider transactions totaling $2.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 2, 2017 involved selling 564 shares valued at $153.0K.
Michel Vounatsos currently holds 39,585 shares of BIOGEN INC. (BIIB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michel Vounatsos has been a net buyer of BIIB stock. They have purchased $2.8M and sold $0 worth of shares.
Michel Vounatsos's most recent insider trade was on May 2, 2017, when they sold 564 shares at $271.34 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 1, 2017 | BIIB | $380.4K | Purchase | 1,402 | $271.35 | Discretionary |
| Feb 27, 2017 | BIIB | $380.4K | Purchase | 1,333 | $285.39 | Discretionary |